DGCI cracks down on Ciplas Montair Plus
The Drug Controller General of India (DCGI) has directed the state drug authority of Silvassa to suspend the license for the manufacture of Montair Plus, a fixed dose combination of montelukast and
The Drug Controller General of India (DCGI) has directed the state drug authority of Silvassa to suspend the license for the manufacture of Montair Plus, a fixed dose combination of montelukast and